Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philip M Sass

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Expert Opinion on Drug Discovery|July 26, 2012
Advances in targeted therapeutic agentsNicholas C Nicolaides, Philip M Sass, Luigi Grasso
Annals of the New York Academy of Sciences|December 31, 2005
Morphogenics as a tool for target discovery and drug developmentNicholas C Nicolaides, Wolfgang Ebel, Brad Kline, et al.
Rapid Communications in Mass Spectrometry : RCM|March 23, 2017
Use of a stable-isotope-labeled reporter peptide and antioxidants for reliable quantification of methionine oxidation in a monoclonal antibody by liquid chromatography/mass spectrometryPilsoo Kang, Tanya Mezhebovsky, Wei Chen, et al.
Plant Biotechnology Journal|December 19, 2006
Rapid generation of plant traits via regulation of DNA mismatch repairQimin Chao, Christine D Sullivan, John M Getz, et al.
Journal of Immune Based Therapies and Vaccines|December 24, 2010
Generation and characterization of high affinity human monoclonal antibodies that neutralize staphylococcal enterotoxin BBrian Drozdowski, Yuhong Zhou, Brad Kline, et al.
Cancer Immunity|March 10, 2007
Preclinical evaluation of MORAb-003, a humanized monoclonal antibody antagonizing folate receptor-alphaWolfgang Ebel, Eric L Routhier, Brian Foley, et al.
Cancer Immunity|December 20, 2007
Preclinical evaluation of MORAb-009, a chimeric antibody targeting tumor-associated mesothelinRaffit Hassan, Wolfgang Ebel, Eric L Routhier, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 1, 2006
Human antibodies for immunotherapy development generated via a human B cell hybridoma technologyJian Li, Tao Sai, Marc Berger, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Expert Opinion on Drug Discovery|July 26, 2012
Advances in targeted therapeutic agentsNicholas C Nicolaides, Philip M Sass, Luigi Grasso
Annals of the New York Academy of Sciences|December 31, 2005
Morphogenics as a tool for target discovery and drug developmentNicholas C Nicolaides, Wolfgang Ebel, Brad Kline, et al.
Rapid Communications in Mass Spectrometry : RCM|March 23, 2017
Use of a stable-isotope-labeled reporter peptide and antioxidants for reliable quantification of methionine oxidation in a monoclonal antibody by liquid chromatography/mass spectrometryPilsoo Kang, Tanya Mezhebovsky, Wei Chen, et al.
Plant Biotechnology Journal|December 19, 2006
Rapid generation of plant traits via regulation of DNA mismatch repairQimin Chao, Christine D Sullivan, John M Getz, et al.
Journal of Immune Based Therapies and Vaccines|December 24, 2010
Generation and characterization of high affinity human monoclonal antibodies that neutralize staphylococcal enterotoxin BBrian Drozdowski, Yuhong Zhou, Brad Kline, et al.
Cancer Immunity|March 10, 2007
Preclinical evaluation of MORAb-003, a humanized monoclonal antibody antagonizing folate receptor-alphaWolfgang Ebel, Eric L Routhier, Brian Foley, et al.
Cancer Immunity|December 20, 2007
Preclinical evaluation of MORAb-009, a chimeric antibody targeting tumor-associated mesothelinRaffit Hassan, Wolfgang Ebel, Eric L Routhier, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 1, 2006
Human antibodies for immunotherapy development generated via a human B cell hybridoma technologyJian Li, Tao Sai, Marc Berger, et al.
Pageof 1